JOHN J. MURRAY
Toronto Western Hospital · 327 works · 15,895 citations · h-index 60
Top works
- Development of the asthma control test
- Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor
- Asthma Control Test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialists
- Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes.
- Release of Prostaglandin D2into Human Airways during Acute Antigen Challenge
- Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. Elucidation of signal transduction pathways.
- Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion
- The Effect of Inhibition of 5-Lipoxygenase by Zileuton in Mild-to-Moderate Asthma
- The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary Disease
- Celecoxib in Patients with Asthma and Aspirin Intolerance
- Prospective Analysis of Sinus Symptoms and Correlation with Paranasal Computed Tomography Scan
- Stabilization and partial characterization of endothelium-derived relaxing factor from cultured bovine aortic endothelial cells
- Rabbit reticulocyte lipoxygenase catalyzes specific 12(S) and 15(S) oxygenation of arachidonoyl-phosphatidylcholine
- Salmeterol Powder Provides Significantly Better Benefit Than Montelukast in Asthmatic Patients Receiving Concomitant Inhaled Corticosteroid Therapy
- Neoplastic meningitis
- Phase III randomized study of sorafenib plus doxorubicin versus sorafenib in patients with advanced hepatocellular carcinoma (HCC): CALGB 80802 (Alliance).
- Allergen-induced Synthesis of F2-Isoprostanes in Atopic Asthmatics: Evidence for Oxidant Stress
- A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings
- Concurrent Use of Salmeterol with Inhaled Corticosteroids is More Effective than Inhaled Corticosteroid Dose Increases
- Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis